About Conference
It is my privilege and sincere honor to have this opportunity to welcome our esteemed speakers and delegates from all around the world to the “7th Edition of International conference on Neuro Oncology and Brain Tumor (Neuro Oncology 2021).
Our presenters and attendees come from an array of academia, clinics, private and government-sponsored laboratories and industries from across the globe. Numerous keynote and scientific presentations as well as poster exhibition presented during this 2-day conference will highlight some of the exciting developments in the fields of Neuro-oncology, brain tumor, pediatric neurooncology and diagnosis process, cancer imaging technologies, and cancer treatment. The conference will also provide attendees the opportunity to make and renew friendships, to network, and to collaborate on future endeavors and research projects. Hopefully, the activity of this conference will contribute to create a brain tumor free world someday.
We hope you will have an academically productive time at the 2021 webinar. Thank you for your participation in Neuro oncology 2021.
Yours Sincerely
Brain Tumor Association
The Conference Neuro Oncology 2021
We are happy to welcome you to the official website of 7th International Conference on Neuro-Oncology and Brain Tumor (Neuro Oncology 2021) webinar during May 24-25, 2021 with the theme of " Neuro Oncology and Treating Brain Tumour challenges with COVID-19 pandemic " which
covers wide range of critically important sessions. It’s a platform to
bring all the neurooncologists and brain tumor specialists together to
share their experiences it’s the amalgam of scientific research as well
as innovative ideas.
Overview of Neuro-oncology and Brain tumour:
An important area of clinical Neuro-Oncology and Brain Tumour that is increasingly relevant as survivorship increases and as patients experience potential morbidities associated with new therapies. Neuro-Oncology is the study of Brain and Spinal cord neoplasms, many of which are (at least eventually) very dangerous and life-threatening (Astrocytoma, Glioma, Glioblastoma multiforme, Ependymoma, Pontine Glioma, and Brain stem tumors are among the many examples of these). Among the Malignant Brain cancers, Gliomas of the brainstem and pons, Glioblastoma multiform, and high-grade (highly anaplastic) Astrocytoma are among the worst.
Geographically market is segmented into Europe, North America, Latin America, Asia pacific, and Middle East and Africa. According to market study, Market Value for Neuro Oncology (i.e. on Brain Cancer and CNS Tumors) will be more than double to $ 623 Million by 2021. A major part of research is going on the top Universities on across the globe. Many companies are associated with various diagnostic instruments and other therapeutics. Besides this various societies and research labs are also associated in this research field.
Who Should Attend?
- Directors
- Head of Department
- Professors
- Industrial Researchers
- Academic Scientist
- Neuro-oncologist
- Brain cancer specialists
- Radiation Oncologists
- Oncologists
- Cancer Pharmaceutical Companies
- Cancer Institutes
- Neuropediatricians
- Neurosurgeons
- Radiation oncologists
- Neuro-Pathologists
- Rehabilitation Specialists
- Research and Development Department.
- Laboratory Professionals
- Ph.D. Students
- Upcoming researchers
- Nursing scholars
- Researchers
- Business Delegates
- Hospital presidents/CEOs/COOs/VPs/trustees
- Hospital c-suite executives (operations, development, finance)
- Healthcare consultants, vendors, and suppliers
- Cancer program marketing and public relations professionals
- Cancer Researchers and Students from academia in the research of Neuro-oncology, Neurooncology Associations, Brain cancer societies, cancer communities, Medical Colleges
Target Audience:
Academia: 65%
Industry: 25%
Others: 10%
Target Audience for the conference are Physicians and Allied Health Professionals in the field of:
- Adult Medical Oncology
- Pediatric Oncology and Hematology
- Neuro-Oncology
- Neurosurgery
- Radiation Oncology
- Neuropathology in cancer
Conference Highlights
Special Issues
- All accepted abstracts will be published in respective Supporting International Journals.
- Abstracts will be provided with Digital Object Identifier by Cross Ref.